Product
CMAB807X
Aliases
Post-change CMAB807X, Pre-change CMAB807X
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Randomized, Double-blind, Parallel Controlled, Phase I Three-arm Study, Comparing the PK, PD, Safety, and Immunogenicity of Pre- and Post-change CMAB807X, Post-change CMAB807X and Xgeva® in Healthy Chinese Male SubjectsStatus: Withdrawn, Estimated PCD: 2024-06-01